UTHR icon

United Therapeutics (UTHR)

NASDAQ

(

NaN%

)

1D
5D
1M
6M
1Y
5Y
After hours

UTHR: / ₿ NaN BTC / NaN Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

$266.98 - $537.19
$22.13B
153.06
43.06M
19.1
-
Yes

What is United Therapeutics (UTHR)?

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

The United Therapeutics (UTHR) stock price has been falling

The United Therapeutics Corporation Common Stock (UTHR) stock after-hours price today is , reflecting a NaN% after-hours move since the market last closed. The company’s market capitalization stands at $22.13B, with a daily trading volume of shares. The previous closing price was .

Get started with United Therapeutics (UTHR)

Ready to get started? Follow the steps below, or read our guide on how to buy United Therapeutics stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy UTHR

Search for UTHR in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy UTHR.

UTHR FAQs

UTHR is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

UTHR is in the Drug Manufacturers - Specialty & Generic industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, United Therapeutics Corporation Common Stock (UTHR) has traded between a low of $266.98 and a high of $537.19.

UTHR is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

Want to invest in United Therapeutics? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
UTHR icon
UTHR

Only available to USA clients through the Kraken app
or Kraken Pro.

Get the Kraken Pro app and buy United Therapeutics in minutes

Kraken App QR Code

Explore other stocks

Most active

Explore the most-traded stocks today

TPET icon
NVDA icon

NVDA

ONDS icon

ONDS

STAK icon

STAK

Top gainers

Browse today’s biggest stock market winners

OTRKQ icon

OTRKQ

PPBT icon
ZCMD icon

ZCMD

TMDE icon

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

BARKW icon

BARKW

ILLRW icon
GOEVQ icon

GOEVQ

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.